Clinical Trial Update: ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating atorvastatin in pulmonary tuberculosis as a population pharmacokinetics/pharmacodynamics sub-study; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: Obafemi Awolowo University Teaching Hospital | Conditions: Pulmonary Tuberculosis (TB) | Phase 2 | Status: RECRUITING